- Representing an oncology biotech company in development IP strategy, identifying and protecting their therapeutic compounds, methods of treatment and companion diagnostics, and building their IP portfolio in over 12 countries.
- Provided IP counsel to a large pharmaceutical company entering the nucleic acid-based therapeutics space, including FTO analysis, development of patent strategy, and patent preparation and prosecution.
- Representing a medical diagnostic company, including preparation of nucleic acid-based diagnostic patent applications, and U.S. and foreign patent prosecution.
- Representing major research universities in providing patentability analyses, and preparation and prosecution of patents over a range of therapeutic, plant, research tool, and molecular biological subjects.
- Prepared patent applications related to COVID-19 therapies and diagnostics for various companies and a research university.
- Conducted IP due diligence and FTO reviews for several companies.
Senior Patent Agent,
- Phone: +1 919 862 2266
- Email: kirk.ekena@alston.com
Kirk's extensive research and intellectual property experience has been a boon to both small biotech and large pharmaceutical companies. Kirk’s clients have come to count on his ability to manage their expansive patent portfolios with a watchful eye and efficient processing.